C3 Glomerulopathy
📧 Sign up to get email alerts when something new happens for C3 Glomerulopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-04-20Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G [Phase 2]
Phase 2 trial of ADX-097 for IgA nephropathy, lupus nephritis, and C3 glomerulopathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-27Clinical Trial Update: TP10 Use in Patients With C3 Glomerulopathy (C3G) [Phase 1]
A Phase 1 trial of TP10 in patients with C3 glomerulopathy (Dense Deposit Disease) has been withdrawn.